Background/Objective: Cortisol is thought to be involved in the pathophysiology of affective disorders. Less attention has been given to other neuroendocrine factors. The aim of the present study was to test the hypothesis that adrenocortical steroids aldosterone and cortisol show different dynamic changes in the course of clinical depression with the assumption that aldosterone is a state marker of depression. Methods: A total of 78 adult subjects (39 patients with depressive disorder and 39 healthy controls) participated in a prospective non-interventional clinical study. Patients were investigated at the time of an acute episode and 6 months after reaching remission. The clinical and personal characteristics, and morning and evening salivary concentrations of aldosterone and cortisol were evaluated. Results: Patients with an acute depressive episode exhibited higher evening aldosterone and lower morning cortisol concentrations compared to healthy subjects. In these patients, both hormone concentrations showed flatter morning to evening slopes. Salivary aldosterone, but not cortisol concentrations, were lower in patients 6 months after reaching remission compared to those in the acute state. Similarly, 6 months of remission resulted in a steeper morning to evening slope of salivary aldosterone compared to the acute state. The cortisol rhythm remained dysregulated. A significant negative correlation between trait anxiety scores and morning cortisol concentrations in patients at 6 months of clinical remission was observed. Conclusion: Diurnal changes in salivary aldosterone concentrations appear to be a state marker, whilst those of cortisol a trait marker of depression.

1.
Jezova
D
,
Hlavacova
N
.
Endocrine factors in stress and psychiatric disorders: focus on anxiety and salivary steroids
.
Ann N Y Acad Sci
.
2008
Dec
;
1148
(
1
):
495
503
.
[PubMed]
0077-8923
2.
Chrousos
GP
.
Stress and disorders of the stress system
.
Nat Rev Endocrinol
.
2009
Jul
;
5
(
7
):
374
81
.
[PubMed]
1759-5029
3.
Tseilikman
V
,
Dremencov
E
,
Tseilikman
O
,
Pavlovicova
M
,
Lacinova
L
,
Jezova
D
.
Role of glucocorticoid- and monoamine-metabolizing enzymes in stress-related psychopathological processes
.
Stress
.
2020
Jan
;
23
(
1
):
1
12
.
[PubMed]
1025-3890
4.
Reul
JM
,
de Kloet
ER
.
Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation
.
Endocrinology
.
1985
Dec
;
117
(
6
):
2505
11
.
[PubMed]
0013-7227
5.
Carroll
BJ
.
The dexamethasone suppression test for melancholia
.
Br J Psychiatry
.
1982
Mar
;
140
(
3
):
292
304
.
[PubMed]
0007-1250
6.
Stetler
C
,
Miller
GE
.
Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research
.
Psychosom Med
.
2011
Feb-Mar
;
73
(
2
):
114
26
.
[PubMed]
0033-3174
7.
Grynderup
MB
,
Kolstad
HA
,
Mikkelsen
S
,
Andersen
JH
,
Bonde
JP
,
Buttenschøn
HN
, et al
A two-year follow-up study of salivary cortisol concentration and the risk of depression
.
Psychoneuroendocrinology
.
2013
Oct
;
38
(
10
):
2042
50
.
[PubMed]
0306-4530
8.
Maripuu
M
,
Wikgren
M
,
Karling
P
,
Adolfsson
R
,
Norrback
KF
. Relative hypo- and hypercortisolism are both associated with depression and lower quality of life in bipolar disorder: a cross-sectional study. PLoS One.
2014
;16;9(6):e98682.
9.
Hlavacova
N
,
Jezova
D
.
Chronic treatment with the mineralocorticoid hormone aldosterone results in increased anxiety-like behavior
.
Horm Behav
.
2008
Jun
;
54
(
1
):
90
7
.
[PubMed]
0018-506X
10.
Hlavacova
N
,
Wes
PD
,
Ondrejcakova
M
,
Flynn
ME
,
Poundstone
PK
,
Babic
S
, et al
Subchronic treatment with aldosterone induces depression-like behaviours and gene expression changes relevant to major depressive disorder
.
Int J Neuropsychopharmacol
.
2012
Mar
;
15
(
2
):
247
65
.
[PubMed]
1461-1457
11.
Jezova
D
,
Balagova
L
,
Chmelova
M
,
Hlavacova
N
.
Classical steroids in a new fashion: focus on testosterone and aldosterone
.
Curr Protein Pept Sci
.
2019
;
20
(
11
):
1112
8
. ;
Epub ahead of print
.
[PubMed]
1389-2037
12.
Geerling
JC
,
Kawata
M
,
Loewy
AD
.
Aldosterone-sensitive neurons in the rat central nervous system
.
J Comp Neurol
.
2006
Jan
;
494
(
3
):
515
27
.
[PubMed]
0021-9967
13.
Büttner
M
,
Jezova
D
,
Greene
B
,
Konrad
C
,
Kircher
T
,
Murck
H
.
Target-based biomarker selection - Mineralocorticoid receptor-related biomarkers and treatment outcome in major depression
.
J Psychiatr Res
.
2015
Jul-Aug
;
66-67
:
24
37
.
[PubMed]
0022-3956
14.
Segeda
V
,
Izakova
L
,
Hlavacova
N
,
Bednarova
A
,
Jezova
D
.
Aldosterone concentrations in saliva reflect the duration and severity of depressive episode in a sex dependent manner
.
J Psychiatr Res
.
2017
Aug
;
91
:
164
8
.
[PubMed]
0022-3956
15.
Ustohal
L
,
Hlavacova
N
,
Mayerova
M
,
Ceskova
E
,
Jezova
D
.
Aldosterone and aldosterone/cortisol ratio is higher in serum of long-term compared to first episode schizophrenia patients: A pilot study
.
J Psychiatr Res
.
2018
Sep
;
104
:
46
9
.
[PubMed]
0022-3956
16.
Sonino
N
,
Fallo
F
,
Fava
GA
.
Psychological aspects of primary aldosteronism
.
Psychother Psychosom
.
2006
;
75
(
5
):
327
30
.
[PubMed]
0033-3190
17.
Reincke
M
.
Anxiety, depression, and impaired quality of life in primary aldosteronism: why we shouldn’t ignore it!
J Clin Endocrinol Metab
.
2018
Jan
;
103
(
1
):
1
4
.
[PubMed]
0021-972X
18.
Kunugi
H
,
Ida
I
,
Owashi
T
,
Kimura
M
,
Inoue
Y
,
Nakagawa
S
, et al
Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a Multicenter Study
.
Neuropsychopharmacology
.
2006
Jan
;
31
(
1
):
212
20
.
[PubMed]
0893-133X
19.
Vreeburg
SA
,
Hoogendijk
WJ
,
van Pelt
J
,
Derijk
RH
,
Verhagen
JC
,
van Dyck
R
, et al
Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study
.
Arch Gen Psychiatry
.
2009
Jun
;
66
(
6
):
617
26
.
[PubMed]
0003-990X
20.
Lok
A
,
Mocking
RJ
,
Ruhé
HG
,
Visser
I
,
Koeter
MW
,
Assies
J
, et al
Longitudinal hypothalamic-pituitary-adrenal axis trait and state effects in recurrent depression
.
Psychoneuroendocrinology
.
2012
Jul
;
37
(
7
):
892
902
.
[PubMed]
0306-4530
21.
Salvat-Pujol
N
,
Labad
J
,
Urretavizcaya
M
,
de Arriba-Arnau
A
,
Segalàs
C
,
Real
E
, et al
Hypothalamic-pituitary-adrenal axis activity and cognition in major depression: the role of remission status
.
Psychoneuroendocrinology
.
2017
Feb
;
76
:
38
48
.
[PubMed]
0306-4530
22.
Vitale
SG
,
Laganà
AS
,
Muscatello
MR
,
La Rosa
VL
,
Currò
V
,
Pandolfo
G
, et al
Psychopharmacotherapy in Pregnancy and Breastfeeding
.
Obstet Gynecol Surv
.
2016
Dec
;
71
(
12
):
721
33
.
[PubMed]
0029-7828
23.
Bruno
A
,
Laganà
AS
,
Leonardi
V
,
Greco
D
,
Merlino
M
,
Vitale
SG
, et al
Inside-out: the role of anger experience and expression in the development of postpartum mood disorders
.
J Matern Fetal Neonatal Med
.
2018
Nov
;
31
(
22
):
3033
8
.
[PubMed]
1476-7058
24.
von Elm
E
,
Altman
DG
,
Egger
M
,
Pocock
SJ
,
Gøtzsche
PC
,
Vandenbroucke
JP
;
STROBE Initiative
.
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
.
Lancet
.
2007
Oct
;
370
(
9596
):
1453
7
.
[PubMed]
0140-6736
25.
Faul
F
,
Erdfelder
E
,
Lang
AG
,
Buchner
A
.
G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences
.
Behav Res Methods
.
2007
May
;
39
(
2
):
175
91
.
[PubMed]
1554-351X
26.
Spielberger
CD
.
State-trait anxiety inventory: Bibliography
. 2nd ed.
Palo Alto (CA)
:
Consulting Psychologists Press
;
1989
.
27.
Jezova
D
,
Hlavacova
N
,
Makatsori
A
,
Duncko
R
,
Loder
I
,
Hinghofer-Szalkay
H
.
Increased anxiety induced by listening to unpleasant music during stress exposure is associated with reduced blood pressure and ACTH responses in healthy men
.
Neuroendocrinology
.
2013
;
98
(
2
):
144
50
.
[PubMed]
0028-3835
28.
McCormick
IA
.
A simple version of the Rathus Assertiveness Schedule
.
Behav Assess
.
1984
;
7
:
95
9
.0191-5401
29.
Hlavacova
N
,
Kerlik
J
,
Radikova
Z
,
Izakova
L
,
Jezova
D
.
Measurement of salivary aldosterone: validation by low-dose ACTH test and gender differences
.
Endocr Regul
.
2013
Oct
;
47
(
4
):
201
4
.
[PubMed]
1210-0668
30.
Bates
D
,
Mächler
M
,
Bolker
B
,
Walker
S
.
Fitting Linear Mixed-Effects Models Using lme4
.
J Stat Softw
.
2015
;
67
(
1
). 1548-7660
31.
Luke
SG
.
Evaluating significance in linear mixed-effects models in R
.
Behav Res Methods
.
2017
Aug
;
49
(
4
):
1494
502
.
[PubMed]
1554-351X
32.
Hothorn
T
,
Bretz
F
,
Westfall
P
.
Simultaneous inference in general parametric models
.
Biom J
.
2008
Jun
;
50
(
3
):
346
63
.
[PubMed]
0323-3847
33.
Wilcox
R
, editor
.
Introduction to Robust Estimation and Hypothesis Testing
.
Academic Press
;
2012
.
810
pp.•••ISBN: 9780128047811.
34.
Perkins
M
,
Perkins
P
.
Advanced mathematics: a combined course in pure mathematics, statistics and mechanics. New edition
.
HarperCollins Publishers
;
1983
.
640
pp.•••ISBN: 0003222993.
35.
Emanuele
E
,
Geroldi
D
,
Minoretti
P
,
Coen
E
,
Politi
P
.
Increased plasma aldosterone in patients with clinical depression
.
Arch Med Res
.
2005
Sep-Oct
;
36
(
5
):
544
8
.
[PubMed]
0188-4409
36.
Murck
H
,
Held
K
,
Ziegenbein
M
,
Künzel
H
,
Koch
K
,
Steiger
A
.
The renin-angiotensin-aldosterone system in patients with depression compared to controls—a sleep endocrine study
.
BMC Psychiatry
.
2003
Oct
;
3
(
1
):
15
.
[PubMed]
1471-244X
37.
Ostrander
MM
,
Ulrich-Lai
YM
,
Choi
DC
,
Richtand
NM
,
Herman
JP
.
Hypoactivity of the hypothalamo-pituitary-adrenocortical axis during recovery from chronic variable stress
.
Endocrinology
.
2006
Apr
;
147
(
4
):
2008
17
.
[PubMed]
0013-7227
38.
Huang
MC
,
Chuang
SC
,
Tseng
MM
,
Chien
YL
,
Liao
SC
,
Chen
HC
, et al
Cortisol awakening response in patients with bipolar disorder during acute episodes and partial remission: A pilot study
.
Psychiatry Res
.
2017
Dec
;
258
:
594
7
.
[PubMed]
0165-1781
39.
Ter Horst
DM
,
Schene
AH
,
Figueroa
CA
,
Assies
J
,
Lok
A
,
Bockting
CL
, et al
Cortisol, dehydroepiandrosterone sulfate, fatty acids, and their relation in recurrent depression
.
Psychoneuroendocrinology
.
2019
Feb
;
100
:
203
12
.
[PubMed]
0306-4530
40.
Duncko
R
,
Novakova
L
,
Notova
P
,
Stepankova
O
,
Jezova
D
.
Behavioral and neuroendocrine changes during mental stress and repeated treatment with antidepressants in healthy men
.
Ann N Y Acad Sci
.
2004
Jun
;
1018
(
1
):
524
32
.
[PubMed]
0077-8923
41.
Vreeburg
SA
,
Hoogendijk
WJ
,
DeRijk
RH
,
van Dyck
R
,
Smit
JH
,
Zitman
FG
, et al
Salivary cortisol levels and the 2-year course of depressive and anxiety disorders
.
Psychoneuroendocrinology
.
2013
Sep
;
38
(
9
):
1494
502
.
[PubMed]
0306-4530
42.
Bockting
CL
,
Lok
A
,
Visser
I
,
Assies
J
,
Koeter
MW
,
Schene
AH
;
DELTA study group
.
Lower cortisol levels predict recurrence in remitted patients with recurrent depression: a 5.5 year prospective study
.
Psychiatry Res
.
2012
Dec
;
200
(
2-3
):
281
7
.
[PubMed]
0165-1781
43.
Huffziger
S
,
Ebner-Priemer
U
,
Zamoscik
V
,
Reinhard
I
,
Kirsch
P
,
Kuehner
C
.
Effects of mood and rumination on cortisol levels in daily life: an ambulatory assessment study in remitted depressed patients and healthy controls
.
Psychoneuroendocrinology
.
2013
Oct
;
38
(
10
):
2258
67
.
[PubMed]
0306-4530
44.
Mocking
RJ
,
Pellikaan
CM
,
Lok
A
,
Assies
J
,
Ruhé
HG
,
Koeter
MW
, et al
DHEAS and cortisol/DHEAS-ratio in recurrent depression: State, or trait predicting 10-year recurrence?
Psychoneuroendocrinology
.
2015
Sep
;
59
:
91
101
.
[PubMed]
0306-4530
45.
Ahrens
T
,
Deuschle
M
,
Krumm
B
,
van der Pompe
G
,
den Boer
JA
,
Lederbogen
F
.
Pituitary-adrenal and sympathetic nervous system responses to stress in women remitted from recurrent major depression
.
Psychosom Med
.
2008
May
;
70
(
4
):
461
7
.
[PubMed]
0033-3174
46.
Adam
EK
,
Quinn
ME
,
Tavernier
R
,
McQuillan
MT
,
Dahlke
KA
,
Gilbert
KE
.
Diurnal cortisol slopes and mental and physical health outcomes: A systematic review and meta-analysis
.
Psychoneuroendocrinology
.
2017
Sep
;
83
:
25
41
.
[PubMed]
0306-4530
47.
Fischer
S
,
Macare
C
,
Cleare
AJ
.
Hypothalamic-pituitary-adrenal (HPA) axis functioning as predictor of antidepressant response-Meta-analysis
.
Neurosci Biobehav Rev
.
2017
Dec
;
83
:
200
11
.
[PubMed]
0149-7634
48.
Carroll
BJ
,
Ritchie
JC
,
Rogers
H
,
Kim
DK
.
Fast Feedback Inhibition of Adrenocorticotropic Hormone Secretion by Endogenous Cortisol in Humans
.
Neuroendocrinology
.
2019
;
109
(
4
):
299
309
.
[PubMed]
0028-3835
49.
Jezova
D
,
Makatsori
A
,
Duncko
R
,
Moncek
F
,
Jakubek
M
.
High trait anxiety in healthy subjects is associated with low neuroendocrine activity during psychosocial stress
.
Prog Neuropsychopharmacol Biol Psychiatry
.
2004
Dec
;
28
(
8
):
1331
6
.
[PubMed]
0278-5846
50.
Hlavacova
N
,
Solarikova
P
,
Marko
M
,
Brezina
I
,
Jezova
D
.
Blunted cortisol response to psychosocial stress in atopic patients is associated with decrease in salivary alpha-amylase and aldosterone: focus on sex and menstrual cycle phase
.
Psychoneuroendocrinology
.
2017
Apr
;
78
:
31
8
.
[PubMed]
0306-4530
51.
Rajcani
J
,
Solarikova
P
,
Buzgoova
K
,
Brezina
I
,
Jezova
D
.
Patients with atopy exhibit reduced cortisol awakening response but not cortisol concentrations during the rest of the day
.
Immunol Res
.
2019
Jun
;
67
(
2-3
):
176
81
.
[PubMed]
0257-277X
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.